SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer.
Nat Cancer
; 1(8): 784-788, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-691527
ABSTRACT
In 84,246 consecutive Italians tested for SARS-CoV-2, we examined the prevalence of cancer and clinical outcomes of viral infection. Overall, 5.7% (4,789/84,246) had previously been diagnosed with cancer and, among the SARS-CoV-2-positive (CV2+ve) patients, 7.8% had a cancer diagnosis (723/9,275). Prevalence of cancer was not associated with risk of infection (odds ratio of 0.97; 95% confidence interval of 0.89-1.06). The proportion of CV2+ve people hospitalized was higher among patients with cancer (56.6 versus 34.4% among other people), and so was the proportion of deaths (14.7% versus 4.5%). The risk of adverse outcomes of SARS-CoV-2 infection was significantly higher for patients with cancer versus those without, particularly for males and older people.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Registries
/
SARS-CoV-2
/
COVID-19
/
Neoplasms
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Nat Cancer
Year:
2020
Document Type:
Article
Affiliation country:
S43018-020-0104-9
Similar
MEDLINE
...
LILACS
LIS